Loading clinical trials...
Loading clinical trials...
The investigators aim to test the hypothesis and to proof thank to laser speckle contrast imaging that post-occlusive reactive hyperemia (PORH) can be induced through a tumor, in this case, through a ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Institut Curie
NCT05955924 · Non-melanoma Skin Cancer, Carcinoma, Squamous Cell, and more
NCT05133427 · Carcinoma, Basal Cell
NCT00218868 · Carcinoma, Basal Cell, Porokeratosis, Disseminated Superficial Actinic
NCT04362722 · Carcinoma, Basal Cell, Carcinoma, Cutaneous Squamous Cell
NCT03769285 · Non-melanoma Skin Cancer, Carcinoma, Squamous Cell, and more
Institut Curie
Paris
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions